Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome. 2011

Mariangela Gulisano, and Paola V Calì, and Andrea E Cavanna, and Clare Eddy, and Hugh Rickards, and Renata Rizzo
Section of Child Neurology, Department of Pediatrics, Catania University, Catania, Italy.

The pharmacotherapy for tic management in Tourette syndrome (TS) relies on neuroleptics, which have been associated with electrocardiographic abnormalities, including QTc interval prolongation. This study assessed the cardiovascular safety of the newer antipsychotic aripiprazole in comparison with the neuroleptic pimozide among young patients affected by TS. Fifty patients aged 6-18 years were assigned to either pimozide (n = 25; mean daily dose 4.4 mg/die) or aripiprazole (n = 25; 5.3 mg/die) treatment for up to 24 months. All patients underwent five serial cardiovascular assessments (baseline, 6, 12, 18 and 24 months). The group treated with pimozide showed significant changes in blood pressure (decreased), QT and QTc (both prolonged). The aripiprazole group showed changes from baseline to peak values in blood pressure (increased), whilst modifications in QT and QTc were not statistically significant. At equivalent doses, aripiprazole is characterised by a safer cardiovascular profile than pimozide, being associated with a lower frequency of QTc prolongation.

UI MeSH Term Description Entries
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D010868 Pimozide A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403) Antalon,Orap,Orap forte,R-6238,R6238
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D005879 Tourette Syndrome A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79) Gilles de la Tourette Disorder,Gilles de la Tourette's Disease,Tic Disorder, Combined Vocal and Multiple Motor,Chronic Motor and Vocal Tic Disorder,Combined Multiple Motor and Vocal Tic Disorder,Combined Vocal and Multiple Motor Tic Disorder,Gilles De La Tourette's Syndrome,Gilles de la Tourette Syndrome,Multiple Motor and Vocal Tic Disorder, Combined,Tourette Disease,Tourette Disorder,Tourette's Disease,Tourette's Disorder,Tourette's Syndrome,Syndrome, Tourette,Tourettes Disease,Tourettes Disorder,Tourettes Syndrome

Related Publications

Mariangela Gulisano, and Paola V Calì, and Andrea E Cavanna, and Clare Eddy, and Hugh Rickards, and Renata Rizzo
December 2012, Pediatric neurology,
Mariangela Gulisano, and Paola V Calì, and Andrea E Cavanna, and Clare Eddy, and Hugh Rickards, and Renata Rizzo
June 2015, Journal of clinical psychopharmacology,
Mariangela Gulisano, and Paola V Calì, and Andrea E Cavanna, and Clare Eddy, and Hugh Rickards, and Renata Rizzo
January 2006, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry,
Mariangela Gulisano, and Paola V Calì, and Andrea E Cavanna, and Clare Eddy, and Hugh Rickards, and Renata Rizzo
September 2004, Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999),
Mariangela Gulisano, and Paola V Calì, and Andrea E Cavanna, and Clare Eddy, and Hugh Rickards, and Renata Rizzo
June 2012, Journal of psychopharmacology (Oxford, England),
Mariangela Gulisano, and Paola V Calì, and Andrea E Cavanna, and Clare Eddy, and Hugh Rickards, and Renata Rizzo
February 2005, Journal of clinical psychopharmacology,
Mariangela Gulisano, and Paola V Calì, and Andrea E Cavanna, and Clare Eddy, and Hugh Rickards, and Renata Rizzo
September 1983, The American journal of psychiatry,
Mariangela Gulisano, and Paola V Calì, and Andrea E Cavanna, and Clare Eddy, and Hugh Rickards, and Renata Rizzo
January 1977, Lancet (London, England),
Mariangela Gulisano, and Paola V Calì, and Andrea E Cavanna, and Clare Eddy, and Hugh Rickards, and Renata Rizzo
April 2006, Journal of child neurology,
Mariangela Gulisano, and Paola V Calì, and Andrea E Cavanna, and Clare Eddy, and Hugh Rickards, and Renata Rizzo
June 2007, Revista medica de Chile,
Copied contents to your clipboard!